Business
Sernova: The Ultimate Combination of Two Proven Technologies as Potential Functional Cure for Type 1 Diabetes and Other Chronic Diseases
(TheNewswire) Information Session Webinar on Sernova’s Conformal Coati...
About this update from Sernova Biotherapeutics Inc
[{"type":"text","content":"Sernova: The Ultimate Combination of Two Proven Technologies as Potential Functional Cure for Type 1 Diabetes and Other Chronic Diseases\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n Information\nSession Webinar on Sernova’s Conformal Coating Immune Protection\nTechnology with Dr. Toleikis and International Expert, Dr. Tomei Now\nAvailable on Sernova’s Website\n \n \n \n \n L\n \n \n ondon, Ontario - TheNewswire\n-\n \n \n October 1, 2021 - Sernova Corp.\n(TSXV:SVA)(OTC:SEOVF) (FSE/XETRA:PSH), a leading clinical-stage\nregenerative medicine company developing a ‘functional cure’ for\ntype 1 diabetes (T1D) and other chronic diseases, recently hosted an\ninformation session webinar. The webinar announced Sernova’s\ncollaboration with the University of Miami (UMiami) and associate\nprofessor and international expert in immunoprotection and diabetes\nengineering, Dr. Alice Tomei of the UMiami’s Diabetes Research\nInstitute. During this webinar Drs. Toleikis and Tomei discussed  the\n Conformal Coating Immunoprotection Technology and its pivotal role\nwithin Sernova’s Cell Pouch Technology platform.  A\n \n \n Q&A session followed the presentation by Drs. Toleikis\nand Tomei. The responses to key questions asked by attendees are\nsummarized below.\n \n \n \n \n For those investors and other interest parties who were\nunable to attend the information session,\n \n \n a\nrecording is available at\n \n \n \n www.sernova.com\n \n \n \n \n \n At what stage of development is the\nConformal Coating Immunoprotection Technology?\n \n \n \n \n This technology is backed by over 12 years of\nscientific research. Scientific research has included extensive\npreclinical testing followed by optimization to arrive at the final\nformulation which is being tested in Sernova’s Cell Pouch.\n \n \n \n \n Have islets with Conformal Coating\nbeen shown to be safe in preclinical models?\n \n \n \n \n Yes. A positive safety profile has been demonstrated in\nsmall and large animal preclinical models.\n \n \n \n \n Does the Conformal Coating affect the\nrelease of insulin from islets tested in the lab?\n \n \n \n \n Insulin release in conformal coated islets is\ncomparable to uncoated islets. Conformal coated islets have shown\nuptake of glucose and the release of insulin remains norma...